Arterium launches an infusion product Neohec 6% onto Ukrainian market
In March 2014, Arterium launches a new medicinal product, Neogec, onto Ukrainian market. The product is a 6% solution for infusion used in threatened or manifested blood volume decrease and shock. The medicinal product is manufactured in 500 ml vials.
Neohecis a multicomponent medicinal product, a generic of the reference drug Tetraspan 6%, solution for infusion, (manufacturer - B. Braun Melsungen AG/ B. Braun Medical S.A., Germany/Switzerland).
The product belongs to pharmacological groupcalled blood substituents and perfusion solutions; hydroxyethylated starch solutions.
Urgency of this medicinal product is confirmed by the fact that balanced infusion therapy holds a prominent place in prevention and therapy of postsurgical complications.
Product Marketing Authorization Holder is Galychpharm PJSC; the manufacture is contracted to Novopharm-Biosynthesis LLC.
The product information is presented in abbreviated form. Complete medicinal product information can be found in the instruction for medical use.
The website is a specialized edition intended for medical and pharmaceutical specialists.